ArticleHuman vaccines & immunotherapeutics2026
Optimizing pneumococcal prevention in South African older adults: Cost-effectiveness of PCV20 versus PPSV23 in the context of HIV-associated risk.
Wei-Wei Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.